Compounds > phenformin
Page last updated: 2024-08-18

phenformin and Neuroblastoma

phenformin has been researched along with Neuroblastoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Benes, CH; Boikos, SA; Calbert, ML; Dalton, KM; Dozmorov, M; Egan, RK; Faber, AC; Floros, KV; Glod, J; Greninger, P; Hu, B; Koblinski, J; Kurupi, R; Lochmann, TL; McClanaghan, J; Murchie, E; Puchalapalli, M; Ramamoorthy, S; Shock, L; Stein, GT1
Chen, X; Decker, M; Fritz, A; Higuchi, T; Kimura, H; Koshino, K; Nose, N; Rowe, SP; Werner, RA; Yagi, Y1
Hsiao, R; Ikegaki, N; Limpar, MM; Lomahan, S; Maloney, NJ; Tang, XX; Tran, TA; Wang, SS1
Bianchi, A; Caraci, F; Chiechio, S; Chisari, M; Frasca, G; Pinto, A; Salomone, S; Sortino, MA1
Jope, RS; King, TD; Song, L1

Other Studies

5 other study(ies) available for phenformin and Neuroblastoma

ArticleYear
Catastrophic ATP loss underlies a metabolic combination therapy tailored for
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 03-30, Volume: 118, Issue:13

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basigin; Cell Line, Tumor; Cell Proliferation; Electron Transport Complex I; Gene Amplification; Humans; Mice; Mitochondria; Monocarboxylic Acid Transporters; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phenformin; Pyrimidinones; Symporters; Thiophenes; Xenograft Model Antitumor Assays

2021
Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
    Molecular imaging and biology, 2020, Volume: 22, Issue:3

    Topics: Animals; Autoradiography; Cell Line, Tumor; Fluorine Radioisotopes; Male; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Phenformin; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution

2020
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
    International journal of molecular medicine, 2014, Volume: 33, Issue:1

    Topics: 3-Iodobenzylguanidine; Acetylation; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Metformin; Mitochondria; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Phenformin; Proto-Oncogene Proteins c-myc; Up-Regulation

2014
Effects of phenformin on the proliferation of human tumor cell lines.
    Life sciences, 2003, Dec-19, Volume: 74, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Culture Media; Glucose; Humans; Hypoglycemic Agents; Male; Neuroblastoma; Oncogene Protein p21(ras); Phenformin; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles

2003
AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.
    Biochemical pharmacology, 2006, May-28, Volume: 71, Issue:11

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Carbachol; Cell Line, Tumor; Enzyme Activation; Glycogen Synthase Kinase 3; Humans; Insulin-Like Growth Factor I; Multienzyme Complexes; Neuroblastoma; Phenformin; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Receptors, Muscarinic; Ribonucleotides

2006